Bd helps advance health equity for women in kenya through critical cancer screening

Collaboration with kenya ministry of health national cancer institute aims to expand access to diagnostics, reduce cervical cancer rates nairobi, kenya , jan. 25, 2024 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced a collaboration with the kenyan government through the national cancer institute-kenya to advance access to critical cancer diagnostics for women in kenya. through this program, bd continues to drive its commitment toward progress of advancing health equity to underserved communities around the world.
BDX Ratings Summary
BDX Quant Ranking